Docking studies and development of novel 5-heteroarylamino-2,4-diamino-8-chloropyrimido-[4,5-b]quinolines as potential antimalarials.
Joshi AA, Viswanathan CL, Bioorg Med Chem Lett, 2006 May 15 - link